The Overseas Investors Chamber of Commerce and Industry (OICCI) has expressed its concerns for not fulfilling the legal obligations of timely implementing the price adjustment mechanism provided under the Drug Pricing Policy of 2018 by the Drug Regulatory Authority Pakistan (Drap) and the federal government. The OICCI was the representative body of top 200 foreign investors in Pakistan which regularly conducts surveys of its members on matters related to the business environment in Pakistan. (more)